BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17964663)

  • 1. TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice.
    Downey J; Smith A; Schneider H; Hogg N; Rudd CE
    Immunol Lett; 2008 Jan; 115(1):70-2. PubMed ID: 17964663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL-associated antigen-4 ligation induces rapid T cell polarization that depends on phosphatidylinositol 3-kinase, Vav-1, Cdc42, and myosin light chain kinase.
    Wei B; da Rocha Dias S; Wang H; Rudd CE
    J Immunol; 2007 Jul; 179(1):400-8. PubMed ID: 17579061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
    Martin M; Schneider H; Azouz A; Rudd CE
    J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory regulation of T cell function.
    Chambers CA; Allison JP
    Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function.
    Schneider H; Valk E; da Rocha Dias S; Wei B; Rudd CE
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12861-6. PubMed ID: 16126897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
    Yi LA; Hajialiasgar S; Chuang E
    Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus.
    Jury EC; Flores-Borja F; Kalsi HS; Lazarus M; Isenberg DA; Mauri C; Ehrenstein MR
    Eur J Immunol; 2010 Feb; 40(2):569-78. PubMed ID: 19950182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization.
    Schneider H; Smith X; Liu H; Bismuth G; Rudd CE
    Eur J Immunol; 2008 Jan; 38(1):40-7. PubMed ID: 18095376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.
    Olsson C; Riesbeck K; Dohlsten M; Michaëlsson E
    J Biol Chem; 1999 May; 274(20):14400-5. PubMed ID: 10318864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte-associated antigen-4 inhibits integrin-mediated stimulation.
    Gatta L; Calviello G; Di Nicuolo F; Pace L; Ubaldi V; Doria G; Pioli C
    Immunology; 2002 Oct; 107(2):209-16. PubMed ID: 12383200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CTLA-4 in immune regulation.
    Verhagen J; Sabatos CA; Wraith DC
    Immunol Lett; 2008 Jan; 115(1):73-4. PubMed ID: 18035425
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
    Fallarino F; Fields PE; Gajewski TF
    J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
    Chen W; Jin W; Wahl SM
    J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 can function as a negative regulator of T cell activation.
    Walunas TL; Lenschow DJ; Bakker CY; Linsley PS; Freeman GJ; Green JM; Thompson CB; Bluestone JA
    Immunity; 1994 Aug; 1(5):405-13. PubMed ID: 7882171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.